From liquid handcuffs to miracle molecule: MOTAA would expand methadone access and help fight the overdose epidemic
Kayla was referred to our addiction clinic after a visit to the emergency department for a skin infection, common in people who use drugs intravenously. Recognizing her fentanyl use was escalating out of her control, she made an appointment to discuss starting buprenorphine, a mainstay of treatment for opioid use disorder (OUD). While our initial office visit with Kayla was straightforward and optimistic, during subsequent visits she continued to experience …












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






![Why I would never compromise on withdrawing care until I saw it firsthand [PODCAST]](https://kevinmd.com/wp-content/uploads/Gemini_Generated_Image_6l3h566l3h566l3h-190x100.png)


